Peterson Amy C.

Officer at EXEL; EVP, Chief Development Officer at CTMX; CMO, Immuno-oncology at BGNE

Sold, on record
$12.1M
Dollars the filings state
Form 4 sales
7
Latest May 16, 2025
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • EXELEXELIXIS, INC.Officer
  • CTMXCytomX Therapeutics, Inc.EVP, Chief Development Officer
  • BGNEBeOne Medicines Ltd.CMO, Immuno-oncology

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale BGNEUnusual
    Nov 13, 2017 2017

    Sold 3,601 shares at $82.96 ($299k)

    Peterson Amy C., CMO, Immuno-oncology

    Sold 100% of holdings ($299k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BGNEUnusual
    Aug 23, 2018 +283 days

    Sold 5,769 shares at $169.12 ($976k)

    Peterson Amy C., CMO, Immuno-oncology

    Sold 100% of holdings ($976k position)0 shares leftFiling

  3. 3 Form 4 sale BGNEUnusual
    Nov 12, 2018 +81 days

    Sold 40,000 shares at $120.20 ($4.8M)

    Peterson Amy C., CMO, Immuno-oncology

    Sold 100% of holdings ($4.8M position)0 shares leftFiling

  4. 4 Form 4 sale BGNEUnusual
    Dec 18, 2018 +36 days

    Sold 20,000 shares at $133.68 ($2.7M)

    Peterson Amy C., CMO, Immuno-oncology

    Sold 100% of holdings ($2.7M position)0 shares left3.5x usual sizeFiling

  5. 5 Form 4 sale CTMXPlan not stated
    Jul 20, 2022 +1310 days

    Sold 7,463 shares at $1.42 ($11k)

    Peterson Amy C., EVP, Chief Development Officer

    Sold 10.6% of holdings ($100k position)62,690 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale CTMXNo plan
    Mar 16, 2023 +239 days

    Sold 4,257 shares at $1.98 ($8k)

    Peterson Amy C., EVP, Chief Development Officer

    No 10b5-1 planSold 6.8% of holdings ($124k position)58,433 shares leftFiling

  7. 7 Form 144 notice EXELNotice
    May 16, 2025 +792 days

    Filed to sell 72,776 shares ($3.4M)

    Peterson Amy C., Officer

    10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 sale EXELNo plan
    May 16, 2025 same day

    Sold 72,776 shares at $45.47 ($3.3M)

    Peterson Amy C., EVP Prod Dev & Med Aff & CMO

    No 10b5-1 planSold 13.5% of holdings ($24.5M position)465,393 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Peterson Amy C.
Source
May 16, 2025May 16, 2025EXELEVP Prod Dev & Med Aff & CMOForm 4 sale72,776$3.3M13.5%No planSEC
May 16, 2025May 16, 2025EXELOfficerForm 144 notice72,776$3.4MNoticeSEC
Mar 16, 2023Mar 20, 2023CTMXEVP, Chief Development OfficerForm 4 sale4,257$8k6.8%No planSEC
Jul 20, 2022Jul 21, 2022CTMXEVP, Chief Development OfficerForm 4 sale7,463$11k10.6%Plan not statedSEC
Dec 18, 2018Dec 19, 2018BGNECMO, Immuno-oncologyForm 4 sale20,000$2.7M100.0%UnusualSEC
Nov 12, 2018Nov 13, 2018BGNECMO, Immuno-oncologyForm 4 sale40,000$4.8M100.0%UnusualSEC
Aug 23, 2018Aug 24, 2018BGNECMO, Immuno-oncologyForm 4 sale5,769$976k100.0%UnusualSEC
Nov 13, 2017Nov 15, 2017BGNECMO, Immuno-oncologyForm 4 sale3,601$299k100.0%UnusualSEC